© 2000 by Oxford University Press
Journal of the National Cancer Institute, Vol. 92, No. 11, 872A-873,
June 7, 2000
© 2000 Oxford University Press
NEWS |
Awards, Appointments, Announcements
Five researchers received the General Motors Cancer Research Foundation Awards in early June.The Alfred P. Sloan Jr. Prize was awarded to Avram Hershko, M.D., Ph.D., professor of biochemistry, Technion–Israel Institute of Technology; and Alexander J. Varshavsky, Ph.D., professor of cell biology, California Institute of Technology, for the discovery of the ubiquitin system for protein degradation and the crucial functions of this system in cellular regulation. The Sloan Prize honors the most outstanding recent basic science contribution to cancer research.
The Charles F. Kettering Prize was given to Monroe E. Wall, Ph.D., chief scientist, Research Triangle Institute; and Mansukh C. Wani, Ph.D., principal scientist, Research Triangle Institute, for the discovery of two chemotherapeutic compounds—CamptothecinTM and Taxol®. The Kettering Prize recognizes the most outstanding recent contribution to the diagnosis or treatment of cancer.
Bert Vogelstein, M.D., professor of oncology, Johns Hopkins University, Baltimore, received the Charles S. Mott Prize for his role in defining the molecular pathogenesis of colorectal cancer. The Mott Prize honors the most outstanding recent contribution to the discovery of the cause or ultimate prevention of human cancer.
|
Researchers Awarded
The Cancer Research Institute awarded the William B. Coley Award for Distinguished Research in Basic and Tumor Immunology to Michael Pfreundschuh, M.D., of the University of Saarlandes, Homburg, Germany; and Mark Davis, Ph.D., of the Stanford University School of Medicine. The award recognizes outstanding achievements in the field of basic immunology and cancer immunology.
CRI also awarded the Oliver R. Grace Award for Distinguished Service in Advancing Cancer Research to Walter Gubert, vice chairman of J.P. Morgan & Co. Inc., in recognition of his company’s role in helping make primary health care services available to underserved communities; and Franz B. Humer, chief executive officer of Hoffmann-La Roche, in recognition of his company’s international stature in the discovery, development, and manufacture of innovative new pharmaceuticals to treat unmet medical needs in diseases such as cancer.
The awards were presented at a ceremony in New York on May 24.
Agus Appointed
David B. Agus, M.D., joined the staff of Cedars-Sinai Medical Center, Los Angeles, as the research director of its new Prostate Cancer Institute.
|
Prior to his appointment, Agus was the head of the Laboratory of Tumor Biology at Memorial Sloan-Kettering Cancer Center, New York, and assistant professor of medicine at Cornell University Medical Center, New York.
Legislators Honored
The Lymphoma Research Foundation of America awarded the Paul E. Tsongas Memorial Award to four legislators in a ceremony in May.
The recipients were Sen. Barbara Boxer (D-Calif.), Sen. Harry Reid (D-Nev.), Rep. Patrick Kennedy (D-R.I.), and Rep. John Edward Porter (R-Ill.).
The Tsongas Award was established to recognize outstanding legislative leadership and commitment in support of important health care issues.
Officers Elected
John R. Wingard, M.D., director of the Bone Marrow Transplant Program at the University of Florida College of Medicine in Gainesville, was elected vice president of the American Society for Blood and Marrow Transplantation at the organization’s annual meeting in April. He will become president in 2002.
Others elected include treasurer: Julie Marie Vose, M.D., University of Nebraska Medical Center, Omaha; director: Stephen J. Forman, M.D., City of Hope National Medical Center, Duarte, Calif.; director: C. Fred LeMaistre, M.D., South Texas Cancer Institute, San Antonio; and director: Beverly J. Torok-Storb, M.D., Fred Hutchinson Cancer Research Center, Seattle.
Richard J. O’Reilly, M.D., chair of the Department of Pediatrics and chief of the Bone Marrow Transplantation Service at Memorial Sloan-Kettering Cancer Center, New York, N.Y., assumed the office of president-elect, and James O. Armitage, M.D., dean of the University of Nebraska College of Medicine, Omaha, was installed as president.
Goldsmith Named
Patricia Goldsmith is the new vice president for institutional and business development at H. Lee Moffitt Cancer Center & Research Institute, Tampa, Fla.
She will be responsible for overseeing the cancer center’s managed care, public relations, marketing, business development, and fund-raising initiatives.
She joined Moffitt in 1995 as vice president of managed care and business development. Prior to this, she served as director of managed care at the University of South Florida College of Medicine.
CiteULike 
Connotea 
Del.icio.us What's this?
| ||||||||||||||||||||||||||||||||||||||||||||